Iambic Therapeutics, Inc. Common Stock (IAM)

Is Iambic Therapeutics, Inc. Common Stock (IAM) A Buy Now?

According to our latest analysis, IAM could be considered a Strong Buy, with 17 technical analysis indicators signaling 11 Buy signals, 0 signaling Sell signals and 6 Neutral signals. This might be a good time to open fresh positions on IAM, as trading bullish markets is always a lot easier

1. RSI (Relative Strength Index): The RSI(14) value of 25.42 indicates that IAM is oversold. This indicates that IAM price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
2. STOCH (Stochastic Oscillator): The STOCH value of 27.26 indicates that IAM is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 0.00 indicates that IAM is oversold. This suggests that IAM price is at or near the lowest level relative to its recent price history.
4. ADX (Average Directional Index): The ADX value of 0.00 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
5. CCI (Commodity Channel Index): A CCI(14) value of -22.13 indicates that IAM is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term IAM price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Iambic Therapeutics, Inc. Common Stock financial reports and earnings history, Iambic Therapeutics, Inc. Common Stock (IAM) stock could reach $725.20 by 2030, $2,498.40 by 2040 and $4,271.60 by 2050. See the projected annual prices until 2050 of the Iambic Therapeutics, Inc. Common Stock stock below:

• Iambic Therapeutics, Inc. Common Stock (IAM) is expected to reach an average price of $1,388.12 in 2035, with a high prediction of $1,611.80 and a low estimate of $822.81. This indicates an +10,275% change from the last recorded price of $13.38.
• Iambic Therapeutics, Inc. Common Stock (IAM) stock is projected to chart a bullish course in 2040, with an average price target of $1,787.18, representing an +13,257% change from its current level. The forecast ranges from a conservative $1,328.48 to a sky-high $2,498.40.
• Our analysts predict Iambic Therapeutics, Inc. Common Stock (IAM) to change +17,985% by 2045, soaring from $1,834.15 to an average price of $2,419.83, potentially reaching $3,385.00. While $1,834.15 is the low estimate, the potential upside is significant.
• Iambic Therapeutics, Inc. Common Stock (IAM) stock is expected to climb by 2050, reaching an average of $2,440.39, a +18,139% change from its current level. However, a wide range of estimates exists, with high and low targets of $4,271.60 and $2,347.61, respectively, highlighting the market's uncertainty.

Iambic Therapeutics, Inc. Common Stock Stock (IAM) Year by Year Forecast